Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil

Detalhes bibliográficos
Autor(a) principal: Portelinha Filho,Alexandre Martins
Data de Publicação: 2009
Outros Autores: Nascimento,Charles Ulloffo do, Tannouri,Talita Nicastro, Troiani,Charlene, Ascêncio,Eloah Lopes, Bonfim,Renata, D'Andrea,Lourdes Aparecida Zampieri, Prestes-Carneiro,Luiz Euribel
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Memórias do Instituto Oswaldo Cruz
Texto Completo: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000700003
Resumo: Few studies are available on hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection in populations living in small and medium-sized Brazilian cities. We evaluated the seroprevalence of these viruses in selected individuals from a clinic of infectology, who were referred to the University Regional Hospital of the West Region of state of São Paulo, Brazil. Among a total of 7,021 individuals seen in the clinic following receipt of preliminary ELISA results or having the suggested clinical signs of viral hepatitis or HIV, 1,228 were systematically screened. Isolated or associated HBsAg, HCV and HIV antibodies were found in 44.9% of the subjects. Anti-HIV antibodies were found in 24.7% of the patients, 20.3% of whom had an HIV monoinfection and 4.4% of whom were co-infected with hepatitis viruses (HCV: 4%; HBV: 0.4%). Anti-HCV antibodies were found in 14% of the patients and 5.9% had anti-HBsAg antibodies. HCV infection affected males more than females (p < 0.05) and individuals > 50-years old had an increased prevalence of anti-HCV compared to HIV (p = 0.0001) or HBV (p = 0.0063). HCV-RNA was detected in 73.5% of the samples with a predominance of genotype 1 (72.5%). A significant percentage (44.9%) of the selected individuals was positive for antibodies against HBV, HCV and/or HIV; these patients would otherwise have remained undiagnosed.
id FIOCRUZ-4_2a497c8e3c75514093c1047146ae8b6a
oai_identifier_str oai:scielo:S0074-02762009000700003
network_acronym_str FIOCRUZ-4
network_name_str Memórias do Instituto Oswaldo Cruz
spelling Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazilhepatitis B virushepatitis C virushuman immunodeficiency virus co-infectionHCV genotypesseroprevalenceSão PauloFew studies are available on hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection in populations living in small and medium-sized Brazilian cities. We evaluated the seroprevalence of these viruses in selected individuals from a clinic of infectology, who were referred to the University Regional Hospital of the West Region of state of São Paulo, Brazil. Among a total of 7,021 individuals seen in the clinic following receipt of preliminary ELISA results or having the suggested clinical signs of viral hepatitis or HIV, 1,228 were systematically screened. Isolated or associated HBsAg, HCV and HIV antibodies were found in 44.9% of the subjects. Anti-HIV antibodies were found in 24.7% of the patients, 20.3% of whom had an HIV monoinfection and 4.4% of whom were co-infected with hepatitis viruses (HCV: 4%; HBV: 0.4%). Anti-HCV antibodies were found in 14% of the patients and 5.9% had anti-HBsAg antibodies. HCV infection affected males more than females (p < 0.05) and individuals > 50-years old had an increased prevalence of anti-HCV compared to HIV (p = 0.0001) or HBV (p = 0.0063). HCV-RNA was detected in 73.5% of the samples with a predominance of genotype 1 (72.5%). A significant percentage (44.9%) of the selected individuals was positive for antibodies against HBV, HCV and/or HIV; these patients would otherwise have remained undiagnosed.Instituto Oswaldo Cruz, Ministério da Saúde2009-11-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000700003Memórias do Instituto Oswaldo Cruz v.104 n.7 2009reponame:Memórias do Instituto Oswaldo Cruzinstname:Fundação Oswaldo Cruzinstacron:FIOCRUZ10.1590/S0074-02762009000700003info:eu-repo/semantics/openAccessPortelinha Filho,Alexandre MartinsNascimento,Charles Ulloffo doTannouri,Talita NicastroTroiani,CharleneAscêncio,Eloah LopesBonfim,RenataD'Andrea,Lourdes Aparecida ZampieriPrestes-Carneiro,Luiz Euribeleng2020-04-25T17:50:32Zhttp://www.scielo.br/oai/scielo-oai.php0074-02761678-8060opendoar:null2020-04-26 02:16:28.055Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruztrue
dc.title.none.fl_str_mv Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil
title Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil
spellingShingle Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil
Portelinha Filho,Alexandre Martins
hepatitis B virus
hepatitis C virus
human immunodeficiency virus co-infection
HCV genotypes
seroprevalence
São Paulo
title_short Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil
title_full Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil
title_fullStr Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil
title_full_unstemmed Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil
title_sort Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil
author Portelinha Filho,Alexandre Martins
author_facet Portelinha Filho,Alexandre Martins
Nascimento,Charles Ulloffo do
Tannouri,Talita Nicastro
Troiani,Charlene
Ascêncio,Eloah Lopes
Bonfim,Renata
D'Andrea,Lourdes Aparecida Zampieri
Prestes-Carneiro,Luiz Euribel
author_role author
author2 Nascimento,Charles Ulloffo do
Tannouri,Talita Nicastro
Troiani,Charlene
Ascêncio,Eloah Lopes
Bonfim,Renata
D'Andrea,Lourdes Aparecida Zampieri
Prestes-Carneiro,Luiz Euribel
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Portelinha Filho,Alexandre Martins
Nascimento,Charles Ulloffo do
Tannouri,Talita Nicastro
Troiani,Charlene
Ascêncio,Eloah Lopes
Bonfim,Renata
D'Andrea,Lourdes Aparecida Zampieri
Prestes-Carneiro,Luiz Euribel
dc.subject.por.fl_str_mv hepatitis B virus
hepatitis C virus
human immunodeficiency virus co-infection
HCV genotypes
seroprevalence
São Paulo
topic hepatitis B virus
hepatitis C virus
human immunodeficiency virus co-infection
HCV genotypes
seroprevalence
São Paulo
dc.description.none.fl_txt_mv Few studies are available on hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection in populations living in small and medium-sized Brazilian cities. We evaluated the seroprevalence of these viruses in selected individuals from a clinic of infectology, who were referred to the University Regional Hospital of the West Region of state of São Paulo, Brazil. Among a total of 7,021 individuals seen in the clinic following receipt of preliminary ELISA results or having the suggested clinical signs of viral hepatitis or HIV, 1,228 were systematically screened. Isolated or associated HBsAg, HCV and HIV antibodies were found in 44.9% of the subjects. Anti-HIV antibodies were found in 24.7% of the patients, 20.3% of whom had an HIV monoinfection and 4.4% of whom were co-infected with hepatitis viruses (HCV: 4%; HBV: 0.4%). Anti-HCV antibodies were found in 14% of the patients and 5.9% had anti-HBsAg antibodies. HCV infection affected males more than females (p < 0.05) and individuals > 50-years old had an increased prevalence of anti-HCV compared to HIV (p = 0.0001) or HBV (p = 0.0063). HCV-RNA was detected in 73.5% of the samples with a predominance of genotype 1 (72.5%). A significant percentage (44.9%) of the selected individuals was positive for antibodies against HBV, HCV and/or HIV; these patients would otherwise have remained undiagnosed.
description Few studies are available on hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection in populations living in small and medium-sized Brazilian cities. We evaluated the seroprevalence of these viruses in selected individuals from a clinic of infectology, who were referred to the University Regional Hospital of the West Region of state of São Paulo, Brazil. Among a total of 7,021 individuals seen in the clinic following receipt of preliminary ELISA results or having the suggested clinical signs of viral hepatitis or HIV, 1,228 were systematically screened. Isolated or associated HBsAg, HCV and HIV antibodies were found in 44.9% of the subjects. Anti-HIV antibodies were found in 24.7% of the patients, 20.3% of whom had an HIV monoinfection and 4.4% of whom were co-infected with hepatitis viruses (HCV: 4%; HBV: 0.4%). Anti-HCV antibodies were found in 14% of the patients and 5.9% had anti-HBsAg antibodies. HCV infection affected males more than females (p < 0.05) and individuals > 50-years old had an increased prevalence of anti-HCV compared to HIV (p = 0.0001) or HBV (p = 0.0063). HCV-RNA was detected in 73.5% of the samples with a predominance of genotype 1 (72.5%). A significant percentage (44.9%) of the selected individuals was positive for antibodies against HBV, HCV and/or HIV; these patients would otherwise have remained undiagnosed.
publishDate 2009
dc.date.none.fl_str_mv 2009-11-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000700003
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000700003
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0074-02762009000700003
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
dc.source.none.fl_str_mv Memórias do Instituto Oswaldo Cruz v.104 n.7 2009
reponame:Memórias do Instituto Oswaldo Cruz
instname:Fundação Oswaldo Cruz
instacron:FIOCRUZ
reponame_str Memórias do Instituto Oswaldo Cruz
collection Memórias do Instituto Oswaldo Cruz
instname_str Fundação Oswaldo Cruz
instacron_str FIOCRUZ
institution FIOCRUZ
repository.name.fl_str_mv Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruz
repository.mail.fl_str_mv
_version_ 1669937705581019136